The centuries old tried-and-proven Indian Ayurveda science is being tapped for potential formulation to fight coronavirus. In a very interesting development, the CSIR (Council of Scientific & Industrial Research) and CCMB (Centre for Cellular and Molecular Biology), Hyderabad, has entered into an agreement with Kerala-based Arya Vaidya Sala (AVS), Kottakkal, to check the efficacy of Ayurvedic formulations in the fight against coronavirus SARS-CoV-2.

AVS is a 118-years old charitable institution headquartered at Kottakkal in Kerala, which has been engaged in the practice and propagation of Ayurveda. They manufacture more than 500 formulations. CCMB is a premier life science research institute and have been testing, sequencing and growing coronavirus strains in their labs.

In this partnership, AVS will provide standardised Ayurveda formulations. CCMB will test them on the lab-grown coronavirus strains in cell culture system, and check for their anti-viral efficacy.

“If it yields tangible results, the project will lead to a major progress in pharmaceutical industry in India.  While India possesses a lot of ancient wisdom, it has lacked defined regulatory protocols for testing the efficacy of formulations that are based on the ancient texts. In the ongoing fight against the coronavirus, it has become imperative to rigorously test the different treatment possibilities before they are used by the public. 

“At CCMB, we have established an efficacy testing facility for drugs and devices by using the lab-grown coronavirus. This can be used for testing the anti-viral efficacy of Ayurvedic formulations too”, said Dr.  Rakesh Mishra, Director, CCMB. 

“AVS is joining hands with CCMB with the clear objective of attempting to validate classical knowledge of Ayurveda with the aid of modern science. We are hopeful that findings of this study will yield useful therapeutic support in the current situation. The chemical evaluation of the selected formulations showed presence of potent molecules, and they will be investigated further,” said Dr. C T. Sulaiman, Senior Scientist, AVS.

With the allopathic formulations of Covid-19 are either being administered and in some cases in final stages of trials, it will be interesting to see if Ayurveda can provide its own formulation to tackle this deadly disease.

Source link


Please enter your comment!
Please enter your name here